Truvada Prescribing Information
Download Full U.S. Prescribing Information, including BOXED WARNINGS
Adobe Acrobat Reader
Downloading files on this page requires the Adobe Acrobat Reader
|
|
Truvada® (emtricitabine and tenofovir disoproxil fumarate)
| Study Number |
Study Title |
Study Summary |
| GS-01-934 (48 wk) |
A Phase 3, Randomized, Open-Label, Multicenter Study of the Treatment of Antiretroviral-Naive, HIV-1 Infected Subjects
Comparing Tenofovir Disoproxil Fumarate and Emtricitabine in Combination with Efavirenz Versus Combivir® (lamivudine/zidovudine) and Efavirenz"
|
Download Study Summary |
| GS-01-934 (96 wk) |
A Phase 3, Randomized, Open-Label, Multicenter Study of the Treatment of Antiretroviral-Naive, HIV-1 Infected Subjects Comparing Tenofovir Disoproxil Fumarate and Emtricitabine in Combination with Efavirenz Versus Combivir® (lamivudine/zidovudine) and Efavirenz |
Download Study Summary |
| GS-01-934 (144 wk) |
A Phase 3, Randomized, Open-Label, Multicenter Study of the Treatment of Antiretroviral-Naive, HIV-1–Infected Subjects Comparing Tenofovir Disoproxil Fumarate and Emtricitabine in Combination with Efavirenz Versus Combivir® (lamivudine/zidovudine) and Efavirenz |
Download Study Summary |
| GS-DE-164-0106 |
Switch to a completely ONce daily Regimen containing Emtricitabine/Tenofovir – Fixed Dose Combination plus Third QD partner: "SONETT"
|
Download Study Summary |
| GS-US-164-0107 |
Combination of Efavirenz and Truvada® (The COMET Study): A Phase 4 Evaluation of Switching from Twice Daily Zidovudine and Lamivudine (Combivir®) to a Simplified, Once-Daily Regimen of Co-formulated Emtricitabine and Tenofovir Disoproxil Fumarate (Truvada®), in Virologically Suppressed, HIV- Infected Patients Taking Efavirenz |
Download Study Summary |
| GS-US-164-0115 |
Boosted Atazanavir and Truvada Given Once-Daily – the BATON Study: A Phase 4, Prospective, Open-Label, Multi Center Study of the Safety, Efficacy, and Adherence in HIV Infected, Antiretroviral Naïve Subjects Treated with a Simple Once-Daily Regimen
|
Download Study Summary |
| GS-MC-164-0111 |
SWEET Study – Simplification With Easier Emtricitabine and Tenofovir:
A Phase 3, Open Label, Randomized, Parallel Group Study to Compare the
Effect on Prevention and Resolution of Treatment Related Adverse Events
of a Simplified, Once Daily Regimen of a Fixed Dose Combination Tablet
of Emtricitabine and Tenofovir DF Versus Twice Daily Co-formulated
Zidovudine and Lamivudine (Combivir®) or Zidovudine and Lamivudine,
in Virologically Suppressed, HIV Infected Patients Taking Efavirenz.
|
Download Study Summary |
|
